Where does Glaxosmithkline Consumer Healthcare Holdings (US) LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Glaxosmithkline Consumer Healthcare Holdings (US) LLC ranks #16,054 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Glaxosmithkline Consumer Healthcare Holdings (US) LLC's Innovation Score?

Glaxosmithkline Consumer Healthcare Holdings (US) LLC has an Innovation Score of 37.7 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Glaxosmithkline Consumer Healthcare Holdings (US) LLC's patent grant rate increasing or decreasing?

Glaxosmithkline Consumer Healthcare Holdings (US) LLC's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Glaxosmithkline Consumer Healthcare Holdings (US) LLC's patents?

Glaxosmithkline Consumer Healthcare Holdings (US) LLC's patents average 10.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Glaxosmithkline Consumer Healthcare Holdings (US) LLC

Q: How many patents does Glaxosmithkline Consumer Healthcare Holdings (US) LLC hold?

Glaxosmithkline Consumer Healthcare Holdings (US) LLC holds 18 US utility patents granted between 2015 and 2023, spanning 15 technology areas.

Q: What technology areas does Glaxosmithkline Consumer Healthcare Holdings (US) LLC focus on?

Glaxosmithkline Consumer Healthcare Holdings (US) LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 6 patents, ranking #3,449 of 7,163 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Q: How is the Glaxosmithkline Consumer Healthcare Holdings (US) LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 18 granted patents across 15 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glaxosmithkline ranks #16,054 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 15 technology areas.

#16,054
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 10.3
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16054 · US Corporation #16,054 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,054/49,997
PHOTO-FINISH Gehl Foods
CPC-FOCUS A61K · 15 areas
INNOV-THIN 37.7/100
CLAIMS-PAR 10.3 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gehl Foods, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glaxosmithkline’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (27%) Velocity 7.6 pts (20%) Breadth 13.7 pts (36%) Claim depth 6.2 pts (16%)

Qualcomm Incorporated · highest

85
Glaxosmithkline… · this assignee

38
3D Lighting… · lowest

7

What this shows Glaxosmithkline's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glaxosmithkline?

Each dot is one of Glaxosmithkline’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glaxosmithkline’s own 10.3 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Glaxosmithkline vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glaxosmithkline's grants concentrate

Glaxosmithkline Consumer Healthcare Holdings (US) LLC is a focused PatentsView assignee: 15 CPC subclasses with 33.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2015. By volume, Glaxosmithkline sits between Gehl Foods, LLC and Grand-tek Technology Co., Ltd..

Glaxosmithkline's three-year grant acceleration

Glaxosmithkline Consumer Healthcare Holdings (US) LLC shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gehl Foods

18
Gelest

18
Geoservices Equip…

18
Gilead Connecticut

18
Global Graphics S…

18
GONG io

18
Grand Rounds

18
Grand-tek Technol…

18
Glaxosmithkline C… ◀

18

What this shows Glaxosmithkline holds 18 patents at rank #16,046, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Glaxosmithkline

By rank, the assignees closest to #16,046 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Glaxosmithkline's primary technology class.

Glaxosmithkline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Glaxosmithkline Consumer Healthcare Holdings (US) LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.6%
2017	1	5.6%
2018	1	5.6%
2019	6	33.3%
2021	1	5.6%
2022	6	33.3%
2023	2	11.1%

Which technologies does Glaxosmithkline Consumer Healthcare Holdings (US) LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

A44C - Personal Adornments, e.g. JEWELLERY; Coins 1

G06F - Electric Digital Data Processing 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A24F - Smokers' REQUISITES; Match BOXES; Simulated Smoking Devices 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

A47J - Kitchen EQUIPMENT; Coffee MILLS; Spice MILLS; Apparatus FOR Making Beverages 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

A46B - Brushes 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Glaxosmithkline Consumer Healthcare Holdings (US) LLC's patent record in context - here's where to go next.

Glaxosmithkline Consumer Healthcare Holdings (US) LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 33.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #16,054 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Glaxosmithkline Consumer Healthcare Holdings (US) LLC against Gehl Foods, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.